Trials / Conditions / Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
3 registered clinical trials studyying Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma NCT04609046 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System NCT01722305 | Mayo Clinic | Phase 1 |